share_log

Mizuho Reiterates Outperform on WAVE Life Sciences, Maintains $19 Price Target

Benzinga ·  Jun 26 00:40

Mizuho analyst Salim Syed reiterates WAVE Life Sciences (NASDAQ:WVE) with a Outperform and maintains $19 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment